Abstract
Scleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1071-1072 |
| Number of pages | 2 |
| Journal | Archives of Dermatology |
| Volume | 137 |
| Issue number | 8 |
| State | Published - 2001 |
ASJC Scopus subject areas
- Dermatology